Here’s why Ramsay Health Care shares have been demolishing the stock market

Ramsay Health Care Ltd (ASX: RHC) shares have been outperforming large parts of the market lately.

The healthcare stock fell 6.2% to $41.76 on Monday — yet the bigger picture tells a different story. Despite the pullback, it’s still up 18% over the past month.

Ramsay Health Care shares are comfortably outperforming the S&P/ASX 200 Index (ASX: XJO), which has slipped 3.2% over the same period.

Investors are increasingly warming to Ramsay Health Care shares as signs emerge that its long-awaited earnings recovery could finally be gathering pace.

Competitive scale with ageing population

Ramsay is Australia’s largest private hospital operator, running more than 70 hospitals and healthcare facilities across the country and maintaining a large international footprint in Europe and the UK.

That scale gives the company a powerful competitive position in a sector where demand tends to grow steadily over time as populations age and healthcare needs expand.

More patients, increased case complexity

The company’s latest financial results highlighted why investors are starting to pay attention again. It reported strong first-half FY26 results, with improvements across key metrics that were well received by investors.

Revenue for the six months to 31 December 2025 rose 9.7% to $9.34 billion, driven by higher patient activity and increased case complexity across its network.

Profit for Ramsay Health Care shares also rebounded, with net profit after tax reaching $160.7 million, compared with a loss a year earlier. Underlying EBIT increased 7.3% to $536.7 million.

Exploring options for European hospital

While that level of profit growth might not appear spectacular at first glance, the market is focusing on the bigger picture. Ramsay is benefiting from improving hospital utilisation rates, stronger revenue indexation in Australia, and ongoing operational improvements.

Another factor driving optimism for the Ramsay Health Care shares is the company’s strategic repositioning. Management has been exploring options for its European hospital arm, Ramsay Santé. Investors hope that simplifying the group and focusing more heavily on core Australian operations could unlock value and improve margins in the years ahead.

Healthcare demand itself remains a powerful tailwind. With ageing populations and rising demand for surgical procedures, many analysts expect long-term patient volumes to keep increasing.

Private hospitals are a critical part of Australia’s healthcare system. Ramsay’s large network gives it significant bargaining power with insurers and the ability to spread costs across a vast operating footprint.

Labour costs main challenge

Still, the investment case for Ramsay Health Care shares is not without risk. Labour costs remain one of the biggest pressures facing hospital operators globally. Ramsay employs 90,000 staff, and wage inflation has been squeezing margins across the healthcare sector.

Investors should also remember that Ramsay’s earnings growth has been uneven in recent years. While revenue has continued to expand, profits have historically been more volatile due to cost pressures and operational disruptions.

What next for Ramsay Health Care shares?

Ramsay Health Care has returned to profitability and is expanding margins — a clear sign that momentum is improving.

Strong cash flow and rising dividends highlight tighter financial discipline, while its scale across Australia and Europe means earnings aren’t reliant on a single market. Earnings are forecast to grow strongly in the coming years. Projections suggest profits could expand by more than 30% annually as margins recover and operational efficiencies improve. 

Broker sentiment remains mixed on Ramsay Health Care shares. Across the market, the stock carries a hold rating. The average 12-month price target sits at $42.56 per share, which suggests a 2% upside.

The post Here’s why Ramsay Health Care shares have been demolishing the stock market appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• 32 ASX shares about to go ex-dividend
• Buy, hold, sell: HMC Capital, Ramsay Health Care, and Sigma shares
• 5 of the best ASX 200 stocks to buy and hold in February revealed
• What is Morgans saying about Ramsay Healthcare and Karoon Energy shares?

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.